Which patients improve the most after arthritis rehabilitation? A study of predictors in patients with inflamatory arthritis in northern Europe, the star-etic collaboration

Journal of Rehabilitation Medicine

Volumn 46, Issue 3, 2014, Pages 250-257

  Hagel, Sofia ^a   Lindqvist, Elisabet ^a   Petersson, Ingemar F ^a   Meesters, Jorit J L ^b,c   Klokkerud, Mari ^c   Aanerud, Gerd J ^c   Stovgaard, Inger H ^d   Hørslev Petersen, Kim ^d   Strömbeck, Britta ^a   Vliet Vlieland, Thea P M ^b   Bremander, Ann ^a,e,f  

^a LUND UNIVERSITY   (Sweden)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DIAKONHJEMMET HOSPITAL   (Norway)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e School of Business and Engineering   (Sweden)

^f Research and Development Centre   (Sweden)

Author keywords

Ankylosing spondylitis; Quality of life; Rehabilitation; Rheumatoid arthritis

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; ANKYLOSING SPONDYLITIS; ARTICLE; COMORBIDITY; EUROPE; FATIGUE; FEMALE; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PAIN; PAIN ASSESSMENT; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SELF CONCEPT; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; ARTHRITIS, RHEUMATOID; COMORBIDITY; EUROPE; FATIGUE; FEMALE; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SELF EFFICACY; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME;

EID: 84894665378     PISSN: 16501977     EISSN: None     Source Type: Journal    
DOI: 10.2340/16501977-1267     Document Type: Article

References (54)

1. Sokka T. Long-term outcomes of rheumatoid arthritis. Curr Opin Rheumatol 2009; 21: 284-290.
2. Kievit W, Fransen J, Adang EM, den Broeder AA, Bernelot Moens HJ, Visser H, et al. Long-term effectiveness and safety of TNFblocking agents in daily clinical practice: results from the Dutch Rheumatoid Arthritis Monitoring register. Rheumatology (Oxford) 2011; 50: 196-203.
3. Mease PJ, Woolley JM, Singh A, Tsuji W, Dunn M, Chiou CF. Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritis. J Rheumatol 2010; 37: 1221-1227.
4. Scire CA, Verstappen SM, Mirjafari H, Bunn DK, Lunt M, Montecucco C, et al. Reduction of long-term disability in inflammatory polyarthritis by early and persistent suppression of joint inflammation: results from the Norfolk Arthritis Register. Arthritis Care Res (Hoboken) 2011; 63: 945-952.
5. Ovayolu N, Ovayolu O, Karadag G. Health-related quality of life in ankylosing spondylitis, fibromyalgia syndrome, and rheumatoid arthritis: a comparison with a selected sample of healthy individuals. Clin Rheumatol 2011; 30: 655-664.
6. Kiltz U, van der Heijde D. Health-related quality of life in patients with rheumatoid arthritis and in patients with ankylosing spondylitis. Clin Exp Rheumatol 2009; 27: S108-S111.
7. Strand V, Khanna D. The impact of rheumatoid arthritis and treatment on patients' lives. Clin Exp Rheumatol 2010; 28: S32-S40.
8. West E, Wallberg-Jonsson S. Health-related quality of life in Swedish men and women with early rheumatoid arthritis. Gend Med 2009; 6: 544-554.
9. Tugwell P, Boers M. Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT Committee. J Rheumatol 1993; 20: 555-556.
10. Gladman DD, Mease PJ, Strand V, Healy P, Helliwell PS, Fitzgerald O, et al. Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 2007; 34: 1167-1170.
11. Vliet Vlieland TP. Rehabilitation of people with rheumatoid arthritis. Best Pract Res Clin Rheumatol 2003; 17: 847-861.
12. Vliet Vlieland TP. Multidisciplinary team care and outcomes in rheumatoid arthritis. Curr Opin Rheumatol 2004; 16: 153-156.
13. Hagel S, Lindqvist E, Bremander A, Petersson IF. Team-based rehabilitation improves long-term aerobic capacity and health-related quality of life in patients with chronic inflammatory arthritis. Disabil Rehabil 2010; 32: 1686-1696.
14. Tijhuis GJ, Zwinderman AH, Hazes JM, Van Den Hout WB, Breedveld FC, Vliet Vlieland TP. A randomized comparison of care provided by a clinical nurse specialist, an inpatient team, and a day patient team in rheumatoid arthritis. Arthritis Rheum 2002; 47: 525-531.
15. van den Hout WB, de Buck PD, Vliet Vlieland TP. Cost-utility analysis of a multidisciplinary job retention vocational rehabilitation program in patients with chronic arthritis at risk of job loss. Arthritis Rheum 2007; 57: 778-786.
16. de Buck PD, le Cessie S, van den Hout WB, Peeters AJ, Ronday HK, Westedt ML, et al. Randomized comparison of a multidisciplinary job-retention vocational rehabilitation program with usual outpatient care in patients with chronic arthritis at risk for job loss. Arthritis Rheum 2005; 53: 682-690.
17. Des Jarlais DC, Lyles C, Crepaz N. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health 2004; 94: 361-366.
18. Prvu Bettger JA, Stineman MG. Effectiveness of multidisciplinary rehabilitation services in postacute care: state-of-the-science. A review. Arch Phys Med Rehabil 2007; 88: 1526-1534.
19. van Vollenhoven RF, Severens JL. Observational studies: a valuable source for data on the true value of RA therapies. Clin Rheumatol 2011; 30 Suppl 1: S19-S24.
20. O'Donnell S, Li LC, King J, Lauzon C, Finn H, Vliet Vlieland TP. Development of a framework for reporting health service models for managing rheumatoid arthritis. Clin Rheumatol 2010; 29: 151-165.
21. Khanna D, Arnold EL, Pencharz JN, Grossman JM, Traina SB, Lal A, et al. Measuring process of arthritis care: the Arthritis Foundation's quality indicator set for rheumatoid arthritis. Semin Arthritis Rheum 2006; 35: 211-237.
22. Boonen A, Braun J, van der Horst Bruinsma IE, Huang F, Maksymowych W, Kostanjsek N, et al. ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health. Ann Rheum Dis 2010; 69: 102-107.
23. Stucki G, Cieza A, Geyh S, Battistella L, Lloyd J, Symmons D, et al. ICF Core Sets for rheumatoid arthritis. J Rehabil Med 2004; 36 (Suppl 44): 87-93.
24. Klokkerud M, Hagen K, Kjeken I, Bremander A, Horslev-Petersen K, Vliet Vlieland TP, et al. Describing arthritis rehabilitation care. Development of a framework identifying domains and elements of importance for arthritis rehabilitation care. J Rehabil Med 2012; 44: 406-413.
25. Grotle M, Klokkerud M, Kjeken I, Bremander A, Hagel S, Strombeck B, et al. What's in the black box of arthritis rehabilitation? A comparison of rehabilitation practice for patients with inflammatory arthritis in northern Europe. J Rehabil Med 2013; 45: 458-466.
26. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997; 36: 551-559.
27. Ware JE, Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
28. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-145.
29. Ekdahl C, Eberhardt K, Andersson SI, Svensson B. Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol 1988; 17: 263-271.
30. Bloch DA, Lorig K, Brown BW, Jr., Moses LE. Parametric and nonparametric analyses of the same data. Soc Sci Med 1989; 29: 259-260.
31. Lorig K, Holman H. Arthritis Self-Efficacy Scales measure selfefficacy. Arthritis Care Res 1998; 11: 155-157.
32. Nettelbladt P, Hansson L, Stefansson CG, Borgquist L, Nordstrom G. Test characteristics of the Hopkins Symptom Check List-25 (HSCL-25) in Sweden, using the Present State Examination (PSE- 9) as a caseness criterion. Soc Psychiatry Psychiatr Epidemiol 1993; 28: 130-133.
33. Strand V, Boers M, Idzerda L, Kirwan JR, Kvien TK, Tugwell PS, et al. It's good to feel better but it's better to feel good and even better to feel good as soon as possible for as long as possible. Response criteria and the importance of change at OMERACT 10. J Rheumatol 2011; 38: 1720-1727.
34. Norman G. The effectiveness and effects of effect sizes. Adv Health Sci Educ Theory Pract 2003; 8: 183-187.
35. Kristensen LE, Karlsson JA, Englund M, Petersson IF, Saxne T, Geborek P. Presence of peripheral arthritis and male sex predicting continuation of anti-tumor necrosis factor therapy in ankylosing spondylitis: an observational prospective cohort study from the South Swedish Arthritis Treatment Group Register. Arthritis Care Res (Hoboken) 2010; 62: 1362-1369.
36. Dagfinrud H, Kjeken I, Mowinckel P, Hagen KB, Kvien TK. Impact of functional impairment in ankylosing spondylitis: impairment, activity limitation, and participation restrictions. J Rheumatol 2005; 32: 516-523.
37. Dagfinrud H, Vollestad NK, Loge JH, Kvien TK, Mengshoel AM. Fatigue in patients with ankylosing spondylitis: A comparison with the general population and associations with clinical and self-reported measures. Arthritis Rheum 2005; 53: 5-11.
38. Mau W, Listing J, Huscher D, Zeidler H, Zink A. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 2005; 32: 721-728.
39. van den Hout WB, Tijhuis GJ, Hazes JM, Breedveld FC, Vliet Vlieland TP. Cost effectiveness and cost utility analysis of multidisciplinary care in patients with rheumatoid arthritis: a randomised comparison of clinical nurse specialist care, inpatient team care, and day patient team care. Ann Rheum Dis 2003; 62: 308-315.
40. Nicassio PM, Kay MA, Custodio MK, Irwin MR, Olmstead R, Weisman MH. An evaluation of a biopsychosocial framework for health-related quality of life and disability in rheumatoid arthritis. J Psychosom Res 2011; 71: 79-85.
41. Buchbinder R, Bombardier C, Yeung M, Tugwell P. Which outcome measures should be used in rheumatoid arthritis clinical trials? Clinical and quality-of-life measures' responsiveness to treatment in a randomized controlled trial. Arthritis Rheum 1995; 38: 1568-1580.
42. Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford) 2006; 45: 885-889.
43. Jones SD, Koh WH, Steiner A, Garrett SL, Calin A. Fatigue in ankylosing spondylitis: its prevalence and relationship to disease activity, sleep, and other factors. J Rheumatol 1996; 23: 487-490.
44. Kirwan JR, Minnock P, Adebajo A, Bresnihan B, Choy E, de Wit M, et al. Patient perspective: fatigue as a recommended patient centered outcome measure in rheumatoid arthritis. J Rheumatol 2007; 34: 1174-1177.
45. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995; 39: 315-325.
46. Huyser BA, Parker JC, Thoreson R, Smarr KL, Johnson JC, Hoffman R. Predictors of subjective fatigue among individuals with rheumatoid arthritis. Arthritis Rheum 1998; 41: 2230-2237.
47. Margaretten M, Barton J, Julian L, Katz P, Trupin L, Tonner C, et al. Socioeconomic determinants of disability and depression in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2011; 63: 240-246.
48. Bjork M, Trupin L, Thyberg I, Katz P, Yelin E. Differences in activity limitation, pain intensity, and global health in patients with rheumatoid arthritis in Sweden and the USA: a 5-year follow-up. Scand J Rheumatol 2011; 40: 428-432.
49. Harrison MJ, Davies LM, Bansback NJ, Ingram M, Anis AH, Symmons DP. The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review. J Rheumatol 2008; 35: 592-602.
50. Marra CA, Rashidi AA, Guh D, Kopec JA, Abrahamowicz M, Esdaile JM, et al. Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? Qual Life Res 2005; 14: 1333-1344.
51. Lillegraven S, Kristiansen IS, Kvien TK. Comparison of utility measures and their relationship with other health status measures in 1041 patients with rheumatoid arthritis. Ann Rheum Dis 2010; 69: 1762-1767.
52. Bland JM, Altman DG. Regression towards the mean. BMJ 1994; 308: 1499.
53. van der Kooi E, Klarenbeek NB, Guler-Yuksel M, Kerstens PJ, van der Lubbe PA, Westedt ML, et al. A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt study. Ann Rheum Dis 2011; 70: 168-171.
54. Thyberg I, Dahlström Ö, Björk M, Arvidsson P, Thyberg M. Potential of the HAQ score as clinical indicator suggesting comprehensive multidisciplinary assessments: the Swedish TIRA cohort 8 years after diagnosis of RA. Clin Rheumatol 2012; 31: 775-783.